Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MFHAS1 contributors: - updated : 17-11-2005
HGNC name malignant fibrous histiocytoma amplified sequence 1
HGNC id 16982
Location 8p23.1      Physical location : 8.641.998 - 8.751.131
Synonym name
  • MFH (malignant fibrous histiocytomas) amplified sequence with leucine-rich tandem repeats,1 (see TSG8B)
  • Synonym symbol(s) MASL1
    DNA
    TYPE functioning gene
    STRUCTURE 107.00 kb     3 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    EXPRESSION
    Type widely
    constitutive of
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Digestiveintestinelarge intestinecolon  
     mouthtongue  highly
    Lymphoid/Immunelymph node    
     thymus    
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • ATP/GTP-binding site
  • three leucine zipper domains
  • a leucine-rich tandem repeat
  • HOMOLOGY
    Homologene
    FAMILY
    CATEGORY protooncogene
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus
    CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule nucleotide,
    GTP
    protein
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    overexpressed in tumors bearing the 8p amplicon
    tumoral        
    malignant fibrous histiocytomas
    tumoral   translocation    
    of a chimeric transcript of MASL1 exon 1 with a cryptic exon from the genome region at 14q21 in B-cell lymphoma
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS